Clincosm LogoSign in Get a demo

gallbladder carcinoma

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Therapeutic Assistance and Decision-making Algorithms in

Not yet recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • ADBoard
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Jan 12, 2023

Gallbladder Carcinoma Trial in Shanghai (gemcitabine and oxaliplatin., Afatinib)

Recruiting
  • Gallbladder Carcinoma
  • Shanghai, Shanghai, China
  • +1 more
Dec 21, 2022

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended
  • Distal Bile Duct Adenocarcinoma
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

Bile Duct Carcinoma, Gallbladder Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in Houston (Endoscopic Retrograde

Recruiting
  • Bile Duct Carcinoma
  • +2 more
  • Endoscopic Retrograde Cholangiopancreatography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Comprehensive Genomic Profiling Combined With Real Life Data of

Active, not recruiting
  • Gallbladder Carcinoma
    • Frankfurt am Main, Germany
      Institut für Klinische Krebsforschung IKF GmbH
    Jan 31, 2022

    Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

    Not yet recruiting
    • Advanced Biliary Tract Cancer
    • +3 more
    • Irinotecan Liposome Injection
    • +3 more
    • Hangzhou, Zhejiang, China
      Cancer Hospital of the University of Chinese Academy of Sciences
    Sep 16, 2021

    Biliary Tract Carcinoma, Gallbladder Carcinoma Trial in Toronto (Selumetinib, Cisplatin, Gemcitabine)

    Active, not recruiting
    • Biliary Tract Carcinoma
    • Gallbladder Carcinoma
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 14, 2021

    Cholangiocarcinoma, Gallbladder Carcinoma, Hepatocellular Carcinoma Trial in Xuzhou (biliary stent)

    Completed
    • Cholangiocarcinoma
    • +2 more
    • biliary stent
    • Xuzhou, Jiangsu, China
      Xuzhou Central Hospital
    Nov 18, 2018

    Cholangiocarcinoma, Gallbladder Carcinoma, Biliary Carcinoma Trial in Greece (Gemcitabine-Pazopanib)

    Terminated
    • Cholangiocarcinoma
    • +2 more
    • Athens, Greece
    • +16 more
    Nov 6, 2018

    Gallbladder Carcinoma Trial in Shanghai (Apatinib, Tegafur)

    Unknown status
    • Gallbladder Carcinoma
    • Shanghai, Shanghai, China
      xiao qing xiao qing Jiang
    Oct 9, 2018

    Circulating Exosome Proteomics In Gallbladder Carcinoma Patients

    Unknown status
    • Proteinosis
    • Gallbladder Carcinoma
      • Shanghai, Shanghai, China
        Xinhua Hospital
      Jul 8, 2018

      Biliary Tract Carcinoma, Gallbladder Carcinoma Trial (MEK 162, Gemcitabine, Oxaliplatin)

      Withdrawn
      • Biliary Tract Carcinoma
      • Gallbladder Carcinoma
      • MEK 162
      • +2 more
      • (no location specified)
      Feb 14, 2018

      Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, Gallbladder Carcinoma Trial in United States (Paclitaxel

      Completed
      • Adenocarcinoma of Unknown Primary
      • +16 more
      • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
      • +4 more
      • Chicago, Illinois
      • +7 more
      Dec 8, 2017

      Permission to Collect Blood Over Time for Research

      Terminated
      • Pancreatic Cancer
      • +13 more
      • Observation
      • Stanford, California
        Stanford University School of Medicine
      Jul 6, 2016